Graphic of healthcare providers

About Moderna COVID-19 Vaccine


Summary of changes (last updated March 7, 2022)

  • Updated guidance for moderately or severely immunocompromised people
  • Updated guidance for vaccination following receipt of monoclonal antibodies or convalescent plasma
  • Addition of history of myocarditis or pericarditis after an mRNA COVID-19 vaccine as a precaution to vaccination
  • Considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule



Page last reviewed: March 7, 2022